GMK: Progenics pharmaceuticals

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)159-164
Number of pages6
JournalCurrent Opinion in Investigational Drugs
Volume3
Issue number1
StatePublished - 2002
Externally publishedYes

Fingerprint

Pharmaceutical Technology
Cancer Vaccines
Melanoma
Clinical Trials
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Pharmacology

Cite this

GMK : Progenics pharmaceuticals. / Knutson, Keith L.

In: Current Opinion in Investigational Drugs, Vol. 3, No. 1, 2002, p. 159-164.

Research output: Contribution to journalArticle

@article{40c43e3c4dad4413b2ec6a8101196a7b,
title = "GMK: Progenics pharmaceuticals",
author = "Knutson, {Keith L}",
year = "2002",
language = "English (US)",
volume = "3",
pages = "159--164",
journal = "Current Opinion in Investigational Drugs",
issn = "1354-3784",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - GMK

T2 - Progenics pharmaceuticals

AU - Knutson, Keith L

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0035985634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035985634&partnerID=8YFLogxK

M3 - Article

C2 - 12054067

AN - SCOPUS:0035985634

VL - 3

SP - 159

EP - 164

JO - Current Opinion in Investigational Drugs

JF - Current Opinion in Investigational Drugs

SN - 1354-3784

IS - 1

ER -